Skin Testing to Identify Safe Drugs for Patients with Rocuronium-Induced Anaphylaxis

Overview

Journal Case Rep Anesthesiol

Publisher Wiley

Specialty Anesthesiology

Date 2020 Feb 22

PMID 32082637

Authors

Manzo Suzuki

Hajime Kawase

Azusa Ogita

Hiroyasu Bito

Affiliations

Soon will be listed here.

Abstract

Among patients who develop anaphylaxis during anesthesia, anaphylaxis caused by a neuromuscular blocking agent has the highest incidence. In patients who developed IgE-mediated anaphylaxis, and cross-reactivity among NMBAs is a concern in subsequent anesthetic procedures. We present a patient who developed rocuronium-induced anaphylaxis in whom the skin prick test (SPT) and intradermal test (IDT) could identify a safe drug to use in the subsequent anesthetic procedure. A 32-year-old female developed anaphylactic shock at the induction of general anesthesia. She recovered by administration of hydrocortisone and epinephrine. Skin tests including the SPT followed by the IDT revealed rocuronium as the drug that caused anaphylaxis and vecuronium as a safe drug to use for the subsequent general anesthesia. She safely underwent surgery with general anesthesia using vecuronium one month after the skin testing. There are not many reports on the effectiveness of the SPT followed by IDT in identifying the causative drug as well as a safe drug to use in the subsequent anesthetic procedure following anaphylaxis during anesthesia. The usefulness of the SPT should be re-evaluated.

References

Sadleir P, Clarke R, Bozic B, Platt P . Consequences of proceeding with surgery after resuscitation from intra-operative anaphylaxis. Anaesthesia. 2017; 73(1):32-39. DOI: 10.1111/anae.14106. View

Li J, Best O, Rose M, Green S, Fulton R, Fernando S . Integrating basophil activation tests into evaluation of perioperative anaphylaxis to neuromuscular blocking agents. Br J Anaesth. 2019; 123(1):e135-e143. DOI: 10.1016/j.bja.2019.02.024. View

Heier T, Guttormsen A . Anaphylactic reactions during induction of anaesthesia using rocuronium for muscle relaxation: a report including 3 cases. Acta Anaesthesiol Scand. 2000; 44(7):775-81. DOI: 10.1034/j.1399-6576.2000.440702.x. View

Ramirez L, Pereira A, Chiriac A, Bonnet-Boyer M, Demoly P . Negative predictive value of skin tests to neuromuscular blocking agents. Allergy. 2011; 67(3):439-41. DOI: 10.1111/j.1398-9995.2011.02753.x. View

Chiriac A, Tacquard C, Fadhel N, Pellerin C, Malinovsky J, Mertes P . Safety of subsequent general anaesthesia in patients allergic to neuromuscular blocking agents: value of allergy skin testing. Br J Anaesth. 2018; 120(6):1437-1440. DOI: 10.1016/j.bja.2018.03.004. View

Trautmann A, Seidl C, Stoevesandt J, Seitz C . General anaesthesia-induced anaphylaxis: impact of allergy testing on subsequent anaesthesia. Clin Exp Allergy. 2016; 46(1):125-32. DOI: 10.1111/cea.12632. View

Leysen J, Uyttebroek A, Sabato V, Bridts C, De Clerck L, Ebo D . Predictive value of allergy tests for neuromuscular blocking agents: tackling an unmet need. Clin Exp Allergy. 2014; 44(8):1069-75. DOI: 10.1111/cea.12344. View

Dhonneur G, Combes X, Chassard D, Merle J . Skin sensitivity to rocuronium and vecuronium: a randomized controlled prick-testing study in healthy volunteers. Anesth Analg. 2004; 98(4):986-989. DOI: 10.1213/01.ANE.0000111206.50145.47. View

Leysen J, Bridts C, De Clerck L, Vercauteren M, Lambert J, Weyler J . Allergy to rocuronium: from clinical suspicion to correct diagnosis. Allergy. 2011; 66(8):1014-9. DOI: 10.1111/j.1398-9995.2011.02569.x. View

10.

Reddy J, Cooke P, van Schalkwyk J, Hannam J, Fitzharris P, Mitchell S . Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium. Anesthesiology. 2014; 122(1):39-45. DOI: 10.1097/ALN.0000000000000512. View

11.

McNeil B, Pundir P, Meeker S, Han L, Undem B, Kulka M . Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature. 2014; 519(7542):237-41. PMC: 4359082. DOI: 10.1038/nature14022. View

12.

Mertes P, Alla F, Trechot P, Auroy Y, Jougla E . Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol. 2011; 128(2):366-73. DOI: 10.1016/j.jaci.2011.03.003. View

13.

Ebo D, Fisher M, Hagendorens M, Bridts C, Stevens W . Anaphylaxis during anaesthesia: diagnostic approach. Allergy. 2007; 62(5):471-87. DOI: 10.1111/j.1398-9995.2007.01347.x. View

14.

Berg C, Heier T, Wilhelmsen V, Florvaag E . Rocuronium and cisatracurium-positive skin tests in non-allergic volunteers: determination of drug concentration thresholds using a dilution titration technique. Acta Anaesthesiol Scand. 2003; 47(5):576-82. DOI: 10.1034/j.1399-6576.2003.00093.x. View

15.

Fisher M, Merefield D, Baldo B . Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesia. Br J Anaesth. 1999; 82(5):770-3. DOI: 10.1093/bja/82.5.770. View

16.

Porebski G, Kwiecien K, Pawica M, Kwitniewski M . Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions. Front Immunol. 2019; 9:3027. PMC: 6306423. DOI: 10.3389/fimmu.2018.03027. View